Trial intelligence / Profile preview

Amoxicillin-clavulanate for acute exacerbation of chronic rhinosinusitis

RBR-4twfv7Phase 2Completed

Sponsor
Faculdade de Medicina de Ribeirão Preto
Start
Mar 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of amoxicillin + clavulanate in chronic rhinosinusitis (CRS) (2 arms), sponsored by Faculdade de Medicina de Ribeirão Preto. Started Mar 2013; status: completed.

02

Drugs

amoxicillin + clavulanate
03

Conditions

chronic rhinosinusitis (CRS)

Beyond the preview

Go deeper on RBR-4twfv7.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-4twfv7.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call